Best Home Care Companies In Valencia Near Me

4worldlovers: We are committed to bringing more of our medicines to more people, no matter where they are.

Novartis confirms unconstrained supply for Pluvicto and continues to significantly expand the number of treatment centers

Novartis delivers 12% sales and 21% core operating income growth from continuing operations (in cc¹). Executes Sandoz spin-off, achieves important innovation milestones, and raises FY 2023 guidance

Novartis Pluvicto shows clinically meaningful and highly statistically significant rPFS benefit in patients with PSMA-positive metastatic castration-resistant prostate cancer in the pre-taxane setting

Novartis announced the company’s financial results for the third quarter of 2023.

Treatments for blood cancers and serious blood disorders are advancing rapidly – Novartis is helping lead the way

Novartis has been at the forefront of advances in how blood cancers and serious blood disorders are treated, helping patients live their best lives.

In 2022, we continued to reimagine medicine and deliver on our purpose to improve and extend people's lives.